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SUMMARY. Rutin was isolated from dried leaves and flowers of buckwheat (Fagopyrum esculentum
Moench.). The effects of rutin on angiotensin II–induced hypertrophy of cultured cardiac myocytes and
proliferation of cardiac fibroblasts of neonatal rats were evaluated by analyzing the cell surface area, mea-
suring the protein synthesis rate through 3H-leucine incorporation, and the MTT method. Rutin (0.8 to 8.0
mg/l) exhibited a strong inhibition on the hypertrophy and proliferation. The results suggested that rutin
from buckwheat flowers and leaves might have protective effects on cardiac hypertrophy.
INTRODUCTION
Cardiac hypertrophy is a common complica-
tion of cardiovascular system diseases and an
independent risk factor giving rise to augmented
mortality for cardiovascular diseases, which of-
ten results in congestive heart failure, serious
cardiac dysrhythmia and significant artery
branch disruption. As to the treatment of cardiac
hypertrophy, immunosuppressant cyclosporine
A was generally proved to be effective 1-5, but
the toxicities to kidney cells had limited its clini-
cal application. Many studies 6 discovered that
flavanoids could protect cardial and cerebral is-
chemia, and cardiac arrhythmia. Therefore, the
study and development of new drugs especially
those from natural resources with few side ef-
fects for cardiovascular diseases, has special sig-
nificance.
Buckwheat, Fagopyrum esculentum Moench.
[syn: F. sagittatum Gilib; Polygonum fagopyrum
L.], is a crop for food as well as medicine. It is
native to China and planted widely especially in
the north. Though buckwheat seeds are widely
used as health food, few studies about buck-
wheat flowers and leaves are reported. To our
best knowledge, the whole plant of buckwheat
is rich in flavonoids, and rutin is in the majority
7, which exists mostly in the flowers especially
flower buds followed by leaves. Frost comes
quite early in the north (Inner Mongolia), so
that lots of buckwheat plants are discarded for
can’t fruit in autumn. Subsequent work was car-
ried out to isolate rutin from buckwheat flowers
and leaves, and assess its effects on cardiac hy-
pertrophy with cultured cells.
MATERIALS AND METHODS
Plant materials
Buckwheat, flowers and leaves collected in
late autumn from Ku Lun, Inner Mongolia (Chi-
na), was identified by the Department of Natural
Medicinal Chemistry, North China Coal Medical
College, Tangshan, China. A voucher specimen
is deposited in the Department of Pharmacolo-
gy, North China Coal Medical College, Tang-
shan, China.
Isolation and preparation of rutin
The air-dried flowers and leaves were
grounded, refluxed for 30 min with water (three
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times). The combined water extracts were con-
centrated and evaporated to proper volume, fil-
tered to remove insoluble precipitate. The fil-
trate was dealed with separating agents, cooled
down, centrifugated to semi-solid, and dried in
an oven at 70 °C to obtain a powder extract.
The extract was dissolved with absolute ethanol
to remove the impurities by filtration, then ap-
propriate amount of water was added in, and
the ethanol was evaporated. The filtrate was
concentrated and cooled down to obtain the
crude rutin. The refined rutin (yield 5.26%) was
obtained through further extraction from crude
rutin by MeOH. The extracted rutin with a puri-
ty of 99.8% authenticated by HPLC was identi-
fied by its color, shape, melting point and the
HCl-Mg reaction. The structure was the same as
the standardized rutin by coupling the UV spec-
tra and Agilent 1100 MS, and the data were
identical with those in literature 8.
Cell culture 
Primary cardiac myocytes and fibroblasts
were prepared from 1 to 3-day-old Wistar rats
hearts following the sequential enzymatic diges-
tion method described previously with some
modification 9. Briefly, the hearts were taken
out, the ventricles were separated and minced
into approximately 1 mm3 pieces and digested
sequentially with 0.1 % trypsin for 5-8 min and
0.07% collagenase II three times for 10 min each
time. The cells were collected and cultured in
Dulbecco’s Modified Eagle Medium (DMEM)
supplemented with 10% FBS, 100 U/ml peni-
cillin, and 100 µg/ml streptomycin for 60 min at
37 °C in a 5% CO2 humidified incubator. The fi-
broblasts had already attached to the culture
flasks while the myocytes remained floating.
The suspension was moved to another flask and
incubated for 48h with 0.1mmol/l 5’-Brdu to in-
hibit the growth of nonmyocytes. The attached
fibroblasts were cultured in 10% FBS DMEM.
Induction of hypertrophy and proliferation
Hypertrophy of cardiac myocytes and prolif-
eration of fibroblasts were induced by adding
10–7 mol/l Ang II, a known promoting growth
factor, to serum-free medium.
Experimental groups
The primarily cultured cardiac myocytes and
the third generation fibroblasts (purified by pas-
sage culture) were synchronized with serum-
free DMEM for 24 h as they grew to the proper
density, then both types of cells were grouped
as follows: a) Control group: cultured in serum-
free DMEM: b) Model group: cultured in serum-
free DMEM supplemented with Ang II; c) Rutin
I group: cultured in serum-free DMEM supple-
mented with 0.8 mg/l rutin 30 min prior to Ang
II; d) Rutin II group: Cultured in serum-free
DMEM supplemented with 4.0 mg/l rutin 30 min
prior to Ang II; d) Rutin III group: Cultured in
serum-free DMEM supplemented with 8.0 mg/l
rutin 30 min prior to Ang II.
Cell surface area assay
Cardiac myocytes were dealed with drugs for
7 days (drug supplemented every 24 h, media
changed every 48 h), then the surface area was
determined. In brief, the cells were fallen off by
0.25% trypsin, suspended with 10% FBS DMEM,
and photographed. Totally, surface area of 100
cells in each group, from 5-10 random eyeshots
of 2-3 containers, were analyzed by MoticMed
System 6.0A medical science image analysis sys-
tem to give the mean value (µm2 for unit).
3H-Leu incorporation assay
Primarily cultured cardiac myocytes were
seeded in 96-well plate (3×105 cells/ml, 200 µl
per hole), interfered with drugs, then 3H-Leu in-
corporation quantity was determined to reflect
protein synthesis rate. Briefly, cells were
grouped and dealed with drugs for 24 h follow-
ing the method mentioned above, then co-incu-
bated with 3H-Leu (1 µCi/ml) for another 24 h,
washed thoroughly with D-Hanks, harvested on-
to fiberglass filter membrane, washed with 10%
trichloracetic acid  and dehydrated alcohol. The
torrefied filter membrane was put in liquid scin-
tillation cup containing 4ml scintillation fluid,
and intensity of radioactivity was measured by
liquid scintillation counter (the results expressed
as cpm/well).
Proliferation assay
Cardiac fibroblasts were treated with various
concentrations of rutin for 24 h, and fibroblast
viability was determined by testing mitochondri-
al enzyme function according to the colorimetric
methyl thiazolyl tetrazolium (MTT) method.
Briefly, 20,000 fibroblasts were subcultured into
a 96-well culture plate 24 h prior to synchro-
nization, and dealed with drugs for another 24
h; then, treated with MTT (20 µl, 5mg/ml) 4 h
before the experiment was terminated. The su-
pernatant was removed and DMSO (150 µl) was
added to dissolve formazan; then, the ab-
sorbance, which reflects the proliferation of fi-
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broblasts, was measured by automatic mi-
croplate reader at 490 nm (results expressed as
A490nm). The growth inhibition ratios (GIR) were
calculated to evaluate the effects of different
concerntration rutin. All procedures were ap-
proved by the Ethical Committee for Laboratory
Animals of the North China Coal Medical Col-
lege (Tangshan) and were performed in accor-
dance with the Principles in Animal Care and
Use of the Committee.
Statistical analysis
Data were expressed as mean ± standard de-
viation (S.D). Statistical significances were ana-
lyzed using the ANOVA test. A value of P < 0.05
was considered significant. GIR were calculated
according to the following equation: GIR(%) =
(Amodel-Arutin)/Amodel × 100%, where A is the av-
erage absorbance of three experiments with 6
replicates.
RESULTS 
The effects of buckwheat rutin on cardiac
hypertrophy were studied with cultured cells by
measuring cell surface area and 3H-Leu incorpo-
ration quantity, and the MTT method.
Effects of rutin from buckwheat flowers
and leaves on hypertrophy of cardiac
myocytes 
Surface area of cardiac myocytes in Ang II
(10–7mol/L) group increased significantly com-
pared with that of control group (P < 0.01),
however there was an obvious decrease of sur-
face area in different concentration rutin group
compared with model group and degraded 7.3%
(P < 0.05), 24.9% (P < 0.01), 28.7% (P < 0.01)
respectively in a dose-dependent manner. An
obvious increase of 3H-Leu incorporation in Ang
II group was observed compared with that of
control group (P <0.01). Different concentration
rutin inhibited 3H-Leu incorporation of cultured
cardiac myocytes induced by Ang II and de-
creased 18.3% (P < 0.05), 35.9% (P < 0.01),
50.7% (P < 0.01) respectively compared with
that of model group. The results showed that
3H-Leu incorporation diminished gradually with
the augmentation of rutin concentration in a
dose -dependent manner. The results were giv-
en in Table 1.
Effects of rutin from buckwheat flowers
and leaves on proliferation of cardiac
fibroblasts
The results of MTT showed that Ang II could
Group Surface area (µm2)
3H-Leu incorporation
(cpm/well)
Control 464.49 ± 76.95 126 ± 16.73
Model 721.48 ± 157.39 ## 284 ± 27.75 ##
Rutin I 668.69 ± 130.56 * 232 ± 24.14 *
Rutin II 542.01 ± 89.08 ** 182 ± 15.81 **
Rutin III 514.36 ± 109.33 ** 140 ± 24.49 **
Table 1. Effects of rutin from buckwheat flowers and
leaves on cell surface area and 3H-Leu incorporation
of AngII- induced cultured neonatal rat cardiac my-
ocytes. Values are expressed as mean ±S.D. ##P <
0.01 in comparison to control group; * P < 0.05, ** P <
0.01 in comparison to model group.
Group A490nm Inhibition ratio (%)
Control 0.250 ± 0.058 …
Model 0.319 ± 0.034 ## …
Rutin I 0.256 ± 0.022 ** 19.75
Rutin II 0.216 ± 0.027 ** 32.29
Rutin III 0.169 ± 0.020 ** 47.02
Table 2. Proliferation activity of AngII-induced cardiac
fibroblasts treated with rutin from buckwheat flowers
and leaves. Values are expressed as mean ±S.D. ##P
< 0.01 in comparison to control group; ** P < 0.01 in
comparison to model group.
enhance the proliferation of cardiac fibroblasts,
while rutin in different concentrations could ob-
viously suppress that (P <0.01) and presented a
dose-dependent manner (suppress rate 19.75%,
32.29%, 47.02 %). (See also Table 2). 
DISCUSSION
Cardiac hypertrophy includes hypertrophy of
cardiac myocytes, proliferation of myocardial in-
terstitial cells (mainly fibroblasts), and rebuilding
of extracellular matrix. Many previous studies
focused on hypertrophy of cardiac myocytes,
but in recent years, people gradually learned
that non-myocardial cells (accounting for 70% of
the total number of cells), mainly the fibroblasts
not only had supportive and protective effect on
the structure of cardiac myocytes but also had
autocrine and paracrine function, thus influ-
enced the structure and function of cardiac my-
ocytes. Therefore, researches in the field of car-
diovascular had become focused on cardiac fi-
broblasts. In present study, the effect of rutin
from buckwheat flowers and leaves on Ang II-
induced cardiac fibroblasts had been studied for
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the first time. More over, through the way of
cell culture, influences of hemodynamics and in-
teractions among AngII and other hormones
could be ruled out. Generous investigations
have manifested that AngII has growth factor
like effect and is regularly used to induce car-
diac hypertrophy 10-11. In this study, Ang II
caused significant increase in cell surface area
and 3H-Leu incorporation quantity of cardiac
myocytes, and proliferation of cardiac fibroblasts
in comparison to control group. Rutin signifi-
cantly decreased myocyte cell surface area and
protein synthesis rate, inhibited the proliferation
of fibroblasts, and presented a dose-dependent
manner. This indicated that rutin could inhibit
cardiac hypertrophy induced by Ang II.
At present, the main raw material for extrac-
tion of rutin is buds of Sophora japonica L., with
fewer resources. Buckwheat is a plant resistant
to freezing and barren environment, and is
widely planted in China, the former Soviet
Union, Japan, Poland, France, Canada, and the
United States etc. Therefore, it really has exten-
sive prospects both in exploitation and applica-
tion.
CONCLUSION
On the basis of results obtained, it can be
concluded that buckwheat rutin possesses the
activity of suppressing cardiac hypertrophy. So,
it can be said that buckwheat flowers and leaves
are good natural materials to develop new agent
to treat cardiac hypertrophy, especially in some
cold areas, minority nationality areas, and re-
mote mountainous areas where waste will be
made into treasures.
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